agilon health (NYSE: AGL) CEO O'Rourke named in initial Form 3

Rhea-AI Filing Summary

agilon health, inc. filed an initial Form 3 for Timothy Patrick O'Rourke, who is identified as CEO & President and a director. This filing establishes his status as a reporting person for agilon health under SEC rules. The data shown does not report any purchases, sales, gifts, tax withholdings, derivative exercises, or other transactions, and lists no derivative positions or holding entries at this time.

Key Figures

Reported buy transactions: 0 transactions Reported sell transactions: 0 transactions Reported holding entries: 0 entries

3 metrics

Reported buy transactions 0 transactions Form 3 transactionSummary buyCount

Reported sell transactions 0 transactions Form 3 transactionSummary sellCount

Reported holding entries 0 entries Form 3 holdingEntries field

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 05/11/2026 - 05:05 PM Accepted by SEC EDGAR 05/11/2026 - 05:05 PM Learn about SEC filing dates

FAQ

What does the agilon health (AGL) Form 3 for Timothy Patrick O'Rourke show?

The Form 3 identifies Timothy Patrick O'Rourke as agilon health’s CEO, President, and director. It establishes him as a reporting person but shows no transactions, holdings, or derivative positions in the summarized data.

Does the AGL Form 3 show Timothy O'Rourke buying or selling agilon health shares?

No, the Form 3 summary shows zero buy, sell, acquire, dispose, and other transactions. All related share counts are reported as zero, indicating no trading activity in this filing’s data.

Are there any derivative securities reported for Timothy O'Rourke in agilon health’s Form 3?

The derivative section for Timothy O'Rourke is empty in this Form 3 data. derivativeSummary entries and derivativeTransactionCount are zero, so no options, warrants, or similar derivative positions are listed.

What roles does Timothy Patrick O'Rourke hold at agilon health (AGL) in this Form 3?

Timothy Patrick O'Rourke is reported as both a director and an officer of agilon health. His officer title is CEO & President, and he is not identified as a ten percent owner in this filing.

Does the agilon health Form 3 indicate any gifts or tax-withholding transactions?

No, the giftCount, giftShares, taxWithholdingCount, and taxWithholdingShares fields are all zero. This indicates no gifts or tax-withholding share dispositions are reported in this Form 3 data.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

O'Rourke Timothy Patrick

(Last) (First) (Middle)

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OHIO 43082

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/07/2026

3. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & President

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Mimi Yang, as Attorney-in-Fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)